FDA warns Genen­tech clin­i­cal in­ves­ti­ga­tor work­ing on pre­ven­tive flu an­tivi­ral tri­al

The FDA on Tues­day re­leased a warn­ing let­ter that it sent to a clin­i­cal in­ves­ti­ga­tor in­volved in Genen­tech’s Phase II­Ib tri­al for the an­tivi­ral Xofluza …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.